Concord Drugs Ltd — Important, 24-11-2025: Company Update

Concord Drugs' key promoters and directors have increased their stake through a preferential allotment. S Nagi Reddy acquired additional equity shares and warrants, raising his total holdings to 30,605,300 equity shares and 37,605,300 warrants. Similarly, S Koni Reddy's stake increased to 11,005,430 equity shares and 16,505,430 warrants. Promoter Kumar also increased holdings to 17,781,250 equity shares and 23,281,250 warrants. These acquisitions signify increased promoter confidence and a strengthened commitment to the company's future growth.